Table 3: Mean IOP in the subconjunctival bevacizumab (SCB) and control groups during the follow-up period.

SCB group
Control group
value

IOP 1 month
(mmHg)
14.4 ± 4.712.8 ± 4.80.83
IOP 3 months
(mmHg)
11.8 ± 4.612.8 ± 5.00.44
IOP 6 months
(mmHg)
11.5 ± 3.712.5 ± 4.30.42
IOP 1 year
(mmHg)
13.8 ± 3.613.2 ± 4.90.30
IOP final visit
(mmHg)
14.0 ± 4.711.9 ± 4.70.36